Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of two-dose oral live attenuated human rotavirus vaccine in healthy Chinese infants
2012-005200-18Phase 3
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, attenuated in rotaviral diarrhea, sponsored by GSK.
02
Drugs
rotavirus vaccine, live, attenuated
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2012-005200-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005200-18.